Clinical Trials List
Protocol NumberKN035-CN-006
NCT Number(ClinicalTrials.gov Identfier)-
2023-01-01 - 2023-12-31
Phase II
Terminated2
-
-
Trial Applicant
Orient EuroPharma Co., Ltd.
-
Sponsor
-
-
Trial scale
Taiwan Multiple Center
-
Update
2026/09/15
Investigators and Locations
Co-Principal Investigator
- 林正耀 Division of Hematology & Oncology
- 林建良 Division of Hematology & Oncology
- 高婉真 Division of Hematology & Oncology
- 曹朝榮 Division of Hematology & Oncology
- Shang-Wen Chen Division of Hematology & Oncology
- 陳昭勳 Division of Hematology & Oncology
- 黃文聰 Division of Hematology & Oncology
- 蕭聖諺 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Principal Investigator
Kun-Huei Yeh
Co-Principal Investigator
- 李佳真 Division of Hematology & Oncology
- Ying-Chun Shen Division of Hematology & Oncology
- 林宗哲 Division of Hematology & Oncology
- YU-YUN SHAO Division of Hematology & Oncology
- Chih-Hung Hsu Division of Hematology & Oncology
- 張端瑩 Division of Hematology & Oncology
- 梁逸歆 Division of Hematology & Oncology
- 莊建淮 Division of Hematology & Oncology
- Chiun Hsu Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
- SUNG-HSIN KUO Division of Hematology & Oncology
- 陳國興 Division of Hematology & Oncology
- 黃柏翔 Division of Hematology & Oncology
- TSUNG-HAO LIU Division of Hematology & Oncology
- Ann-Lii Cheng Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Study Contacts
- -
Condition/Disease
-
Objectives
-
Test Drug
-
Active Ingredient
-
Dosage Form
-
Dosage
-
Endpoints
-
Inclution Criteria
-
Exclusion Criteria
-
The Estimated Number of Participants
-
Taiwan
200 participants
-
Global
2000 participants